Pharmaceutical Industry Should Invest Further in Anti-Obesity Drugs

Pharmaceutical organisations should increase their investment in anti-obesity drugs to respond to the rising number of clinically obese people globally. This is the main message from a report by business intelligence specialist, GlobalData, which observes that the obesity market is lucrative, largely driven by the embracement of sedentary lifestyles, high cholesterol diets and reduced physical

Continue Reading

ICON’s MIRA Chosen by Roche for Medical Image Repository

Continuing its move from transactional relationships to strategic alliances with clients, ICON have announced that they have been chosen by Roche as Roche’s technology partner for storing and managing medical images collected during clinical research programmes. ICON is an international supplier of outsourced development services to the pharmaceutical, biotechnology and medical device industries.  The Company

Continue Reading

Only Medics To Attend DGPharMed 2012

Only Medics will be attending DGPharMed’s annual conference at the Hotel Pullman Cologne, in Germany on the 8th and 9th March 2012. 2012 sees the 28th year of the annual conference by the German Society of Pharmaceutical Medicine. The conference starts at 9:20am on Thursday 8th March, and finishes the following day.  The German Society

Continue Reading

UK’s NICE Dismisses Drug Delay Statements

The UK’s National Institute for Health and Clinical Excellence (NICE) has not been requested to alter the basis of their assessments “simply to save money,” NICE’s chief executive, Sir Andrew Dillon, has stated. Sir Andrew Dillon was replying to media reports from earlier this week, which claimed that the UK government is deferring the introduction

Continue Reading

Only Medics at the 2012 BrAPP Annual Symposium

Only Medics will be attending this year’s BrAPP Conference on 1st March 2012 in London. 2012 sees BrAPP celebrating its 55th year as the professional association for pharmaceutical physicians. The conference starts at 9am, and is followed by a three course dinner with guest speaker, Professor Trevor Jones CBE. The conference offers attendees the chance

Continue Reading

Berkeley Lab Discover New Evidence On How ‘Good’ Cholesterol Turns ‘Bad’

Researchers with the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have discovered new proof to clarify how cholesteryl ester transfer protein (CETP) mediates the move of cholesterol from “good” high density lipoproteins (HDLs) to “bad” low density lipoproteins (LDLs). The outcomes of the research study were conveyed in the journal Nature Chemical

Continue Reading